Measurement of activated clotting time in children – comparison of the Celite i‐STAT® ACT with the Medtronic ACT® II

Background:  To evaluate a recently introduced blood‐saving method for the measurement of activated clotting time (ACT), the Celite i‐STAT® ACT, by comparing the values obtained with those from the widely used Medtronic ACT® II device.

[1]  H. Aken,et al.  Near-patient testing--point-of-care or point of costs and convenience? , 2003, British journal of anaesthesia.

[2]  Sharon Grant,et al.  Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a university children's hospital. , 2002, Annals of clinical and laboratory science.

[3]  A. Koster,et al.  The Plasma Supplemented Modified Activated Clotting Time for Monitoring of Heparinization During Cardiopulmonary Bypass: A Pilot Investigation , 2002, Anesthesia and analgesia.

[4]  G. Siskin,et al.  Activated clotting time as a screening test prior to catheter‐based cardiovascular procedures , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  J. Widness,et al.  Phlebotomy Overdraw in the Neonatal Intensive Care Nursery , 2000, Pediatrics.

[6]  A. Harf,et al.  Accuracy of the i-STAT bedside blood gas analyser. , 1999, The European respiratory journal.

[7]  S. Soldin,et al.  Evaluation of i-STAT portable clinical analyzer in a neonatal and pediatric intensive care unit. , 1997, Clinical biochemistry.

[8]  W. Weightman,et al.  Sensitivity and Specificity of the Hemochron, Hemotec and APTT for the Detection of Low Concentrations of Heparin , 1996, Anaesthesia and intensive care.

[9]  M. H. Gault,et al.  Evaluation of i-STAT portable clinical analyzer in a hemodialysis unit. , 1996, Clinical biochemistry.

[10]  P. Eisenberg,et al.  Rational approach to use of heparin during cardiac catheterization in children. , 1995, Journal of the American College of Cardiology.

[11]  J. Ferguson,et al.  The use of activated clotting times to monitor heparin therapy during and after interventional procedures , 1994, Clinical cardiology.

[12]  J. Ferguson,et al.  Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. , 1994, Journal of the American College of Cardiology.

[13]  N. Payne,et al.  Predictive Performance of Three Methods of Activated Clotting Time Measurement in Neonatal ECMO Patients , 1993, ASAIO journal (1992).

[14]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[15]  P. Hattersley.  Activated coagulation time of whole blood. , 1966, JAMA.

[16]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[17]  J. J. Ferguson.  All ACTs are not created equal. , 1992, Texas Heart Institute journal.